Overview
- 6 inspections across 6 sites are on record.
- 13 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-03-24.
At a glance
Inspections
6
Sites
6
Observations
13
Career since
Dec 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. | 24 Mar 2023 | Human Drugs | On file |
| Port Jervis Laboratories, Inc | 4 Nov 2022 | Human Drugs | View 483 → |
| Sciegen Pharmaceuticals Inc | 2 Sep 2022 | Human Drugs | View 483 → |
| Mandell's Clinical Pharmacy | 17 Jun 2022 | Human Drugs | On file |
| Canyon Rush, LLC | 15 Apr 2022 | Human Drugs | View 483 → |
Sites inspected
SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP.New Brunswick, United States1 insp.
Port Jervis Laboratories, IncPort Jervis, United States1 insp.
Sciegen Pharmaceuticals IncHauppauge, United States1 insp.
Mandell's Clinical PharmacySomerset, United States1 insp.
Canyon Rush, LLCRush, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Elaine E Gilfillan1 shared
Barbara J Wilimczyk-Macri1 shared
Karishma G Gopaul1 shared
Juliana M Badalucco1 shared
Syeda N Mahazabin1 shared
Daniel J Min1 shared
Vivin George1 shared
Mindy M Chou1 shared
Adetutu M Gidado1 shared
Sony Mathews1 shared
Full investigator report
Get the verbatim findings behind Sayyem H Akbar's 13 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site